<DOC>
	<DOC>NCT01562041</DOC>
	<brief_summary>The study is designed to evaluate the use of ETT ECG indices as biomarkers in the assessment of atherosclerotic coronary vascular disease (ASCVD).</brief_summary>
	<brief_title>Evaluation of Exercise Treadmill Test Indices in Patients With Cardiovascular Disease</brief_title>
	<detailed_description />
	<mesh_term>Cardiovascular Diseases</mesh_term>
	<mesh_term>Vascular Diseases</mesh_term>
	<mesh_term>Ranolazine</mesh_term>
	<criteria>History of stable coronary artery disease â€¢ Inability or unwillingness to participate in multiple exercise treadmill tests and/or any other requirements of this study as assessed by the Investigator. History of chronic atrial fibrillation. Other protocoldefined inclusion/exclusion criteria may apply.</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>April 2016</verification_date>
	<keyword>Cardiovascular disease</keyword>
	<keyword>Exercise Treadmill Test</keyword>
	<keyword>Ranolazine</keyword>
	<keyword>Angina</keyword>
	<keyword>Myocardial ischemia</keyword>
</DOC>